Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations.
Morita S, Okamoto I, Kobayashi K, Yamazaki K, Asahina H, Inoue A, Hagiwara K, Sunaga N, Yanagitani N, Hida T, Yoshida K, Hirashima T, Yasumoto K, Sugio K, Mitsudomi T, Fukuoka M, Nukiwa T.
Clin Cancer Res. 2009 Jul 1;15(13):4493-8. Epub 2009 Jun 16.PMID: 19531624 [PubMed - indexed for MEDLINE]Related articles